By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Clearmind Medicine Inc.

Clearmind Medicine Inc. (CMND)

NASDAQ Currency in USD
$340.00
-$1.09
-0.32%
Last Update: 18 Jul 2026, 12:54
$43.21m
Market Cap
-11.21
P/E Ratio (TTM)
Forward Dividend Yield
$221.84-$459.70
52 Week Range

CMND Stock Price Chart

Explore Clearmind Medicine Inc. interactive price chart. Choose custom timeframes to analyze CMND price movements and trends.

CMND Company Profile

Discover essential business fundamentals and corporate details for Clearmind Medicine Inc. (CMND) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

15 Nov 2022

Employees

4.00

CEO

Adi Zuloff-Shani

Description

Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.

CMND Financial Timeline

Browse a chronological timeline of Clearmind Medicine Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 15 Jun 2026

EPS came in at -$6.78 .

Stock split effective on 21 May 2026

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 12 Mar 2026

EPS came in at -$3.32 .

Earnings released on 28 Jan 2026

EPS came in at -$4.40 .

Stock split effective on 15 Dec 2025

Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 11 Sept 2025

EPS came in at -$10.00 .

Earnings released on 12 Jun 2025

EPS came in at -$6.40 .

Earnings released on 13 Mar 2025

EPS came in at -$9.60 .

Earnings released on 22 Jan 2025

EPS came in at -$0.11 .

Earnings released on 16 Sept 2024

EPS came in at -$0.59 .

Earnings released on 13 Jun 2024

EPS came in at -$0.28 .

Earnings released on 18 Mar 2024

EPS came in at -$0.90 .

Earnings released on 29 Jan 2024

EPS came in at -$629.05 .

Stock split effective on 28 Nov 2023

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 13 Sept 2023

EPS came in at -$0.08 .

Earnings released on 14 Jun 2023

EPS came in at -$905.91 .

Earnings released on 17 Mar 2023

EPS came in at -$1.32k .

Earnings released on 3 Feb 2023

EPS came in at -$1.97k .

Stock split effective on 3 Oct 2022

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Jul 2022

EPS came in at -$1.84k .

Earnings released on 30 Apr 2022

EPS came in at -$2.95k .

Earnings released on 31 Jan 2022

EPS came in at -$2.01k .

Earnings released on 31 Oct 2021

EPS came in at -$2.39k .

Earnings released on 31 Jul 2021

EPS came in at -$1.24k .

CMND Stock Performance

Access detailed CMND performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run